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Objectives. We used intravascular ultrasound imaging of the 
epicardial vessels to assess coronary morphology, vasomotor 
response to exercise and exercise-vasomotion after beta- 
adrenoceptor blockade in patients with syndrome X. 
Background. Syndrome X is defined as chest pain, abnormal 
exercise test results and normal coronary angiographic findings. 
Because of the limitations of coronary angiography, intravascular 
ultrasound was used to define coronary pathophysiology. 
Methods. Thirty patients with syndrome X were studied with 
intravascular ultrasound imaging (30 MHz, 4.3F catheter) of all 
three major epicardial vessels. Supine arm exercise was per- 
formed uring coronary imaging. Lumen area was assessed at rest 
and during peak exercise. The exercise-imaging protocol was 
repeated after loading with 0.1 mg/kg body weight of intravenous 
propranolol. 
Results. Three morphologic groups were identified using intra- 
vascular ultrasound: normal coronary arteries (no plaque, intimal 
thickness <0.25 mm, n -- 12), atheromatous disease (mean 
[-+SD] area stenosis 37.9 -+ 7.2%, n = 10) and marked intimal 
thickening (0.73 -+ 0.11 mm, n = 8). Patients with normal 
coronary arteries displayed a vasodilatory response to exercise 
(+ 16.9% area increase); patients with abnormal coronary arteries 
displayed a vasoconstrictive response to exercise (-17.4% in the 
group with plaque; -17.6% in the group with intimal thickening). 
Propranolol loading attenuated the vasodilatory response in the 
group with normal coronary arteries (+6.4% area increase) and 
attenuated the vasoconstrictive response in the two groups with 
abnormal coronary arteries (-8.0% in the group with plaque; 
-8.8% in the group with intimal thickening). 
Conclusions. Most patients with syndrome X have abnormal 
coronary arteries by intravascnlar ultrasound. Intravascular ul- 
trasound identifies three distinct morphologic groups: normal 
coronary arteries, atheromatons plaque and intimal thickening. 
Exercise-vasomotion s ormal in patients with syndrome X who 
have normal coronary arteries by ultrasound; patients with ab- 
normal arteries (plaque or intimal thickening) have an abnormal 
(constrictive) response to exercise. Propranolol loading attenu- 
ates vasoreactivity in all subgroups, uggesting divergent thera- 
peutic utility. 
(J Am Coll Cardiol 1995;25:1310-7) 
Normal coronary arteries are found at angiography in as many 
as 20% of patients referred for catheterization because of 
angina (1,2). Mortality in these patients is quite low, but the 
prognosis for symptom relief and return to work is poor (3,4). 
Myocardial ischemia has been documented in this population 
using exercise/thallium stress testing, pacing studies and 
positron emission tomography (5-8). The term "syndrome X" 
is now widely used to describe this cohort of patients. 
Several studies have shown impairment in coronary blood 
flow reserve (9,10) which, when correlated with pathologic 
data (11), has suggested a "microvascular" etiology for the 
angina seen in syndrome X (12,13). Although the evidence for 
a significant role for small-vessel disease is good, the tendency 
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to dismiss the large epicardial arteries as normal and thus 
uninvolved in the pathophysiology of syndrome X may be 
unjustified. 
The standard efinitions of syndrome X have depended on 
angiography for determining the normalcy of the coronary 
circulation. However, angiography is a silhouette technique 
with substantial limitations (14-16). Intravascular ultrasound 
has been validated as having significantly greater sensitivity 
than angiography for delineating arterial wall characteristics 
and for detecting stenoses (16-20). We therefore proposed to 
study patients with syndrome X using intracoronary ultrasound 
of all major vessels to assess definitively epicardial coronary 
artery morphology and the presence or absence of disease. 
Because the issue of coronary reactivity in syndrome X may 
bc crucial in understanding the pathophysiology of the clinical 
syndrome (21), we also analyzed the coronary vasomotor 
response to exercise as assessed by intracoronary ultrasound 
imaging. Finally, because beta-adrenergic blocking agents are 
widely used to treat angina, we repeated our exercise- 
vasomotion i terrogation after propranolol loading to deter- 
mine the effects of this therapy in patients with syndrome X
(22). 
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Methods 
Study group. Thirty patients were studied (19 women, 1 l 
men; mean [_+SD] age 50.40 _+ 5.33 years). Patients were 
selected prospectively on a consecutive basis when the follow- 
ing inclusion criteria were fulfilled: 1) clinical history consistent 
with ischemic exertional chest pain; 2) abnormal exercise stress 
test results (by electrocardiographic criteria); and 3) referral by 
a cardiologist for cardiac atheterization because of suspected 
coronary artery disease. All enrolled patients actually under- 
went stress-imaging (thallium stress or echocardiography), but 
the results of the imaging were not used as criteria for or 
against enrollment. An abnormal stress-imaging study was 
defined as a reversible wall motion abnormality (by echocar- 
diography) or a reversible perfusion defect (by thallium stress). 
Patients with documented coronary artery disease, previous 
myocardial infarction, significant valvular or myocardial dis- 
ease, history of hemodynamically significant arrhythmias or a 
contraindication to beta-blockers were excluded. Patients with 
ST segment elevation during exercise testing or with a clinical 
history suggestive of coronary vasospasm were also excluded. 
Patients receiving beta-blockers were allowed a pharmacologic 
washout period of 72 h before the study. Patients were 
approached before cardiac atheterization; they were enrolled 
only if coronary angiographic findings appeared completely 
normal in multiple orthogonal views. 
The study protocol was approved by the Institutional Re- 
view Board of Columbia-Presbyterian Medical Center, and 
written consent for the study was obtained from all patients 
before coronary angiography. 
Coronary angiography. Diagnostic coronary angiography 
was performed using standard techniques (21,22); images were 
viewed by digital display on a Siemens-HICOR system. Pa- 
tients were enrolled in the study if the performing angiogra- 
pher and one other angiographer who was not a study inves- 
tigator agreed that the coronary arteriographic findings were 
entirely normal. Patients with normal angiographic results 
proceeded toa full intracoronary ultrasound study of the major 
epicardial vessels. The presence of minimal to mild plaque, 
ectasia, myocardial bridging, flow abnormaliV or any other 
abnormal angiographic finding excluded the patient from 
further study. 
Study protocol, lntracoronary ultrasound was performed 
with standard techniques (19,20) using a 4.3F, 30-MHz cathe- 
ter (Cardiovascular Imaging Systems, Inc). The first artery 
imaged was the right coronary artery (to the posterior descend- 
ing artery), followed by the left circumflex coronary artery (or 
largest obtuse marginal if the true left circumflex was small) 
and ending with the left anterior descending coronary artery. 
The catheter was advanced distally in the target artery until 
the arterial diameter exceeded the catheter diameter by only 
0.5 mm (1.9-mm lumen). Imaging was performed uring slow 
manual pullback from the distal vessel; images were acquired 
at 30 frames/s and recorded on 0.5-in. sVHS videotape for 
off-line analysis. At focal depth, axial resolution of the image 
was 150 ixm and lateral resolution 200 ~m; the radius of 
penetration was -5 mm. 
During pullback, we inspected the ultrasound images (dis- 
played on a CVIS INSIGHT System) for gross assessment of
plaque burden and intimal thickness. Exercise imaging was 
performed inthe most abnormal rtery (highest plaque burden 
or greatest intimal thickness in the absence of plaque) or in the 
left anterior descending coronary artery if all arteries were 
entirely normal by intravascular ultrasound. 
Exercise-imaging was performed as follows. The ultrasound 
catheter was advanced to a relatively disease-free segment of 
the target artery, generally in the midportion of the vessel. 
Baseline images were obtained; the catheter was left in place, 
and its position was verified using angiographic and ultrasound 
markers. Supine arm exercise was performed using 1-kg 
weights for >5 min and until at least a 50% increase in heart 
rate was induced. After confirming catheter position, we 
obtained repeat ultrasound images at peak exercise to assess 
changes in lumen area. A 5-rain rest period was introduced, 
after which propranolol, 0.1 mg/kg body weight, was given 
intravenously over a subsequent 5 rain. A rest heart rate <60 
beats/min was achieved in all patients. Baseline lumen area was 
again obtained and supine arm exercise repeated after pro- 
pranolol oading. Exercise was performed for >5 rain and 
terminated atthat period of time which had produced a 50% 
increase in heart rate in each individual patient prior to 
beta-blocker loading. Ultrasound images were again obtained 
at peak exercise. 
The ultrasound catheter was then removed and angiogra- 
pby of all three epicardial arteries was repeated to ensure that 
no damage had been caused by the procedure. Four patients 
were given intracoronary nitroglycerin (200 txg) to alleviate 
catheter-induced coronary spasm; no other adverse angio- 
graphic sequelae were observed. In 14 patients, angina oc- 
curred at peak exercise and was relieved with sublingual 
nitroglycerin (1.6 rag) at the termination of the exercise 
protocol. No intravascular ultrasound images were obtained 
within 10 rain of a contrast or nitroglycerin i jection or within 
20 rain of a sublingual nitroglycerin dose, to avoid any exoge- 
nous effect on coronary reactivity. There were no complica- 
tions related to the procedure in any of the 30 patients. 
Ultrasound analysis. Ultrasound images were recorded on 
0.5-in. sVHS tape and analog-to-digital conversion used Vid- 
eospigot software; the data were transferred to a Macintosh 
IIsi computer and analyzed using NIH Image 1.44 software. 
Lumen area was established by computer-assisted planimetry 
of the lumen/vessel wall interface, averaged over three dia- 
stolic frames. Intimal thickness at target sites was measured as 
the distance between the lumen and the intimal/medial inter- 
face, averaged over three diastolic frames. Plaque area at a target 
site was measured by planimetry of the area bounded by the 
middle echolucent zone (media) and the intima/lumen border. 
Percent area stenosis was calculated as plaque area divided by 
plaque plus lumen area (total area) multiplied by 100%. 
In each artery studied we identified the area of maximal 
intimal thickness and the zone of maximal plaque burden. The 
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Figure 1. Left, Characteristic mage from a 
patient with syndrome X with entirely nor- 
mal epicardial vessels by intravascular ultra- 
sound, displayed from the mid-left anterior 
descending coronary artery. Imaging was 
performed with a 4.3F, 30-MHz catheter; 
marker dots are separated by 0.5 ram. The 
catheter, surrounded by ring artifact, occu- 
pies the center of the lumen. Middle, Image 
from the mid-right coronary artery in a 
patient with syndrome X with atheromatous 
plaque identified by intravascular ultra- 
sound. P = a large eccentric atheroma that 
occupies nearly half of the lumen. Right, 
Image from a patient with syndrome X with 
marked intimal thickening noted by intra- 
vascular ultrasound. A concentrically thick- 
ened intimal band measuring -0.5 mm is 
shown (I). The subjacent sonolucent band 
represents the medial layer. A guide wire 
artifact is visible in the left upper quadrant. 
This image was obtained from the mid-left 
anterior descending coronary artery. 
maximal intimal thickness noted at any point in the corona~ 
tree of a given patient was taken as the index of maximal 
intimal thickness for that patient. Similarly the maximal plaque 
area noted at any point in the coronary tree was taken as the 
index measurement of maximal plaque area in a given patient. 
All measurements were made by a cardiologist experienced 
with intravascular ultrasound and blinded as to patient char- 
acteristics, study phase during imaging (rest vs. exercise) and 
time of propranolol infusion. 
Interobserver and intraobserver variability. The reproduc- 
ibility of intracoronary ultrasound imaging for measuring 
coronary lumen area has been reported to be excellent (20,23). 
In this study we examined interobserver and intraobserver 
variability for measuring intimal thickness and plaque area. 
Five patients (30 sites) were selected randomly and measured 
by one observer at two separate times and once by a second 
observer. These measurements were analyzed as a linear 
regression between the observations and as percent error, 
derived as the absolute difference between observations. Thc 
interobserver variability for intimal thickness was 7% (r = 
0.92); the intraobserver variability was 4% (r : 0.97). The 
interobserver variability for plaque area was 4% (r = 0.98) and 
the intraobserver variability was 3% (r = 0.98). 
Statistics. The unpaired t test was used to compare patient 
subgroups with regard to plaque area or intimal thickness. 
When analyzing data regarding lumen area changes within a 
given patient, we used the paired t test. Differences of vaso- 
motor response between patient subgroups were compared 
using repeated-measures analysis of variance. A value of p < 
0.05 was considered significant. All measurements are ex- 
pressed as mean value _+ SD. 
Resu l ts  
lntravascular ultrasound identified three distinct morpho- 
logic groups in the study patients: 1) patients with entirely 
normal coronary arteries (n = 12), 2) patients with atheroma- 
tous plaque (n : 10) and 3) patients with markedly abnormal 
intimal thickening without evidence of atheromatous plaque 
(n = 8). Ultrasound images characteristic of each group are 
displayed in Figure 1, 
Patient characteristics. Within each intravascular ultra- 
sound morphologic group the mean ages were as follows: 
normal group 49.8 _+ 6.6 years, plaque group 51.0 _+ 4.6 years 
and intimal-thickening group 50.6 _+ 4.5 years. Mean ages and 
gender distribution did not differ significantly among the three 
groups. Major cardiac risk factors (smoking, family history, 
cholesterol ->240 mg/dl, diabetes, hypertension) were assigned 
a score of I and added for each patient o achieve a risk-factor 
score. The mean risk-factor score for the study patients was 
1.73 _+ 0.64. Risk factor scores were 1.50 _+ 0.52 for the group 
with normal coronary arteries, 1.90 _+ 0.74 for the group with 
plaque and 1.88 _+ 0.64 for the group with intimal thickening. 
The risk factor score was somewhat lower in the group with 
normal coronary arteries than in the two groups with abnormal 
coronary arteries, but this difference did not reach statistical 
significance (p = 0.15). 
Morphology. The twelve patients with "true" normal cor- 
onary arteries had no evidence of atheromatous plaque in the 
major epicardial vessels and had a maximal intimal thickness 
<0.25 ram, previously demonstrated to be anatomically normal 
(24,25). The ten patients with atheromatous plaque shown by 
intravascular ultrasound had a mean plaque area of 3.6 _+ 
0.9 mm 2, representing a mean percent area of stenosis of 
37.9 _+ 7.2%. The group with plaque demonstrated modest 
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intimal thickening (mainly at the site of atheroma) with a 
maximal intimal thickness of 0.33 _+ 0.06 mm. The eight 
patients with marked intimal thickening had no atheromatous 
disease and had a maximal intimal thickness of 0.73 _+ 
0.11 ram, which is significantly different from the modest 
intimal thickening seen in the group with plaque (p < 0.001). 
Thus, in this study, the majority (18 [60%] of 30) of patients 
with syndrome X had abnormal epicardial vessels when as- 
sessed by intravascular ultrasound. Individual and mean pa- 
tient data are displayed in Table 1. 
Whereas all patients had abnormal exercise test results, 
only 2 (16.7%) of 12 with normal coronary arteries by intra- 
vascular ultrasound had abnormal stress-imaging study results 
(echocardiography or thallium). In marked contrast, 17 
(94.4%) of 18 patients with abnormal findings by intravascular 
ultrasound (plaque or intimal thickening) also had abnormal 
stress-imaging study results (Table 1) (p < 0.01, for normal vs. 
abnormal imaging results). Patients with intimal thickening 
tended to have multiple ischemic zones; most patients in the 
plaque group had ischemia in the territory of the artery with 
the largest plaque burden as shown by intravascular ultra- 
sound. Thus, abnormal stress-imaging results (but not conven- 
tional stress testing) may identify a group of patients with 
syndrome X who have significant structural abnormalities of
the epicardial vessels by intravascular ultrasound. 
Vasomotion with exercise. Supine exercise was performed 
as described earlier. In the 12 patients with normal intravas- 
cular ultrasound results, baseline heart rate was 79.3 _+ 9.6 
beats/min, and peak heart rate was 144.4 _+ 9.5 beats/rain at 
7.2 _+ 1.2 min of exercise. In the 10 patients with plaque by 
intravascular ultrasound, baseline heart rate was 77.4 _+ 
8.8 beats/rain, and peak heart rate was 144.7 _+ 9.9 beats/rain at 
6.8 _+ 1.1 min of exercise. In the eight patients with marked 
intimal thickening, baseline heart rate was 79.6 _+ 8.4 beats/ 
rain, and peak heart rate was 143.9 _+ 8.5 beats/rain at 6.5 _+ 
1.0 min of exercise. There were no significant differences 
among the groups for baseline heart rate, peak heart rate or 
duration of exercise. Imaging was performed at baseline and at 
peak exercise. Nitroglycerin use at peak exercise did not differ 
among the groups (Table 1). Ultrasound images of typical 
vasomotor responses are displayed in Figures 2 and 3. 
Exercise response was related to morphology by ultrasound. 
Patients with normal intravascular ultrasound results had a 
vasodilatory response of +16.9 _+ 6.7% (p < 0.01) at peak 
exercise. Patients with plaque by ultrasound isplayed avaso- 
constrictive r sponse to exercise with a -17.4 _+ 5.2% decrease 
in area (p < 0.01). Patients with marked intimal thickening 
also had a vasoconstrictive response to exercise with a - 17.6 _+ 
3.5% reduction in area (p < 0.01). 
Thus, patients with syndrome X with normal intravascular 
ultrasound findings in the coronary tree display a normal 
vasodilatory esponse to exercise; those with disease by ultra- 
sound (plaque or intimal thickening) display an abnormal 
vasoconstrictive response to exercise. Morphologic abnormal- 
ities by ultrasound are therefore predictive of abnormal vaso- 
motor function in this patient population. 
Vasomotion after propranolol oading. After a 5-min rest, 
propranolol loading and repeat exercise imaging were per- 
formed as described earlier (Table 1). Baseline lumen areas 
decreased after propranolol loading by 7% in the group with 
normal coronary arteries and by 4% in the two groups with 
abnormal coronary arteries (p < 0.001). 
Patients with normal coronary arteries hown by intravas- 
cular ultrasound exhibited a blunted vasodilatory esponse to 
exercise after propranolol loading, with an increase of only 
+6.4 ± 4.8% in area (p < 0.01 for area change, p < 0.01 vs. 
response before propranolol loading). Patients with plaque 
displayed blunting of their vasoconstrictive response to exer- 
cise after propranolol loading, with a decrease of only -8.0 _+ 
2.8% in area (p < 0.01 within group and vs. previous response). 
Patients with marked intimal thickening also showed ablunting 
of their vasoconstrictive r sponse to exercise, with only a 
-8.1 _+ 2.6% decrease in area (p < 0.01 internally and vs. 
initial exercise response). 
Thus, propranolol loading attenuates the normal vasodila- 
tory response to exercise in patients with syndrome X who have 
normal coronary arteries by intravascular ultrasound. Con- 
versely, patients with abnormal coronary arteries by ultrasound 
(plaque or intimal thickening) display a blunting of their 
pathologic vasoconstrictive r sponse to exercise after beta- 
blockade. 
Discuss ion  
The present study demonstrates that most patients with 
syndrome X have abnormal epicardial vessels when assessed by 
intravascular ultrasound. Three distinct morphologic groups 
were identified; vasomotor response to exercise can be related 
directly to morphology and is attenuated by propanolol in both 
ultrasound normal and abnormal groups. 
Morphologie groups. The three morphologic groups iden- 
tified in our patients with syndrome X did not differ signifi- 
cantly with regard to age, gender or risk factor status. We 
therefore believe that they accurately represent the true mor- 
phologic diversity subsumed under this diagnosis. 
The group with true normal coronary arteries represents 
the least surprising results; ultrasound confirmed the anglo- 
graphic normality of the epicardial vessels. Although these 
patients all had abnormal exercise tests only 2 of 12 had 
abnormal exercise-imaging studies, suggesting that coronary 
perfusion during exercise may in fact be normal in these 
patients. 
The group with atherosclerotic plaque confirms the superi- 
ority of intravascular ultrasound over angiography for detect- 
ing atheroma. The physiologic importance of the identified 
atherosclerosis is supported by both the abnormal vasomotor 
response to exercise and the finding that 9 of 10 of these 
patients had evidence of abnormal perfusion by stress- 
imaging. However, with regard to pathophysiology it isunlikely 
that the 38% area stenosis een in this group was responsible 
for any significant reduction in epicardial coronary blood flow. 
Thus, the epicardial coronary artery disease may simply reflect 
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Table 1. Intravascular Ultrasound Assessment of Morphology and Vasomotor Response 
Patients With Normal Coronary Arteries by Intravascular Ultrasound 
(n - 12; abnormal ETT 12 of 12; abnormal ETl'-imaging 2 of 12) 
Pt No. MLA MLA-EX % Area A MLA-/3B MLA-/3B/EX % Area A 
1 9.6 10.4 + 12.5 9.0 9.6 +6.7 
2 10.3 ll.8 + 14.6 9.8 10.0 +2.0 
3 11.1 12.7 +14.4 10.2 10.1 -1.0 
4 9.4 10.0 +6.4 8.9 9.5 +6.7 
5 10.0 12.1 -21.0 9.5 10.3 +8.4 
6 8.8 9.8 --11.4 8.1 8.0 1.2 
7 7.5 9.5 + 26.7 7.6 8.4 + 10.5 
8 15.2 18.7 +23.0 13.2 15.0 +13.6 
9 6.5 7.9 + 21.5 6.1 6.4 - 4.9 
10 9.0 10.7 + 18.9 8.8 9.2 +4.5 
11 6.5 7.0 + 7.8 6.0 6.7 + 11.7 
12 7.2 9.0 + 25.0 6.3 6.9 +9.5 
Mean 9.3 10.8 + 16.9' 8.6 9.2 +6.4* 
SD 2.4 3.0 6.7 2.0 2.3 4.8 
Patients With Plaque by Intravascular Ultrasound (n = 10; abnormal ETT 10 of 10; abnormal EYT-imaging 9 of 10) 
Pt No. MLA MLA-EX % Area ~5 Max PA Max IT MLA-/3B MLA-/3B/EX % Area A 
1 10.4 8.1 -22.1 2.4 0.31 10.0 9.2 -8.0 
2 7.9 6.5 17.7 3. l /).28 7.7 7.0 -9.1 
3 9.4 8.8 6.4 2.6 0.40 9.0 7.9 12.2 
4 11.5 9.1 20.9 4.5 0.22 11.3 10.8 -4.4 
5 9.1) 8.1 - 10.0 3.8 0.29 8.7 8.0 - 8.8 
6 10.8 8.5 21.3 4.0 0.38 10.4 10.1 -2.9 
7 7.2 6.0 -16.7 3.4 0.41 6.8 6.2 -8.8 
8 12.5 10.0 -20.0 5.2 0.35 11.9 11.0 -7.6 
9 8.8 7.2 -18.2 3.7 0.29 8.7 8.1 -6.9 
10 6.9 5.5 - 20.2 2.8 0.33 6.5 5.8 - 10.8 
Mean 9.4 7.8 17.4" 3.6 [).33- 9.1 8.4 -8.0* 
SD l.t~ 1.4 5.2 0.9 0.06 1.8 1.7 2.8 
Patients With Intimal Thickening by lntravascular Ultrasound 
(n = 8; abnormal ETF 8 of 8; abnormal ETY-imaging 8 of 8) 
Pt No. MLA MLA-EX % Area ~ IT MLA-/3B MLA-/3B/EX % Area A 
1 9.4 8.0 14.9 0.53 9.1 8.5 -6.6 
2 10.6 9.1 -14.2 0.69 10.3 9.6 -6.8 
3 11.7 9.4 -19.7 11.78 11.2 10.4 -7.1 
4 12.2 10.1 17.2 0.66 11.9 11.0 -7.6 
5 9.9 8.6 13.1 1/.82 9.5 9.1 -4.2 
6 7.2 5.5 -23.6 0.75 6.8 6.2 -8.8 
7 I 0.0 8.2 - 18.0 /).87 9.4 8.4 - 10.6 
8 8.9 7.1 - 20.2 0.70 8.6 7.5 - 12.8 
Mean 10.0 8.3 17.6* 0.73t 9.6 8.8 - 8.1 * 
SD 1.6 1.5 3.5 0.11 1.6 1.9 2.6 
*Change (A) in mean lumen area (MLA) (mm 2) with exercise (with and without propranolol) is significant within 
each group and between groups with normal and abnormal intravascular ultrasound findings, with p < 0.01. -tIntimal 
thickness (IT) (mm) in patients with plaque versus those with intimal thickening is significantly different, p < 0.001. 
ETT = exercise tolerance test; Max = maximal; MLA-EX = mean lumen area at peak exercise (mm2); MLA-/3B = mean 
lumen area (mm 2) after propranolol (0.1 mg/kg intravenously); MLA-J3B/EX = mean lumen area (mm 2) at peak exercise 
after propranolol loading; PA - plaque area (mmZ); Pt = patient. 
more  extensive microvascu lar  disease,  which may be of  g reater  
impor t  in view of  its ability to restr ict coronary  flow reserve 
(8 -12) .  Never the less ,  the  large-vessel  a therosc leros is  n these  
pat ients  is suff icient o inter fere with endothe l ia l  funct ion  and 
thus  produce  abnormal  vasomotor  responses ,  wh ich  may in 
turn  cont r ibute  to abnormal i t ies  in flow reserve.  
The  most  surpr is ing morpho log ic  g roup  is that  with marked  
int imal  th icken ing by int ravascular  u l t rasound.  In t imal  thick- 
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Figure 2. Intravascular ultrasound 
image of a normal mid-left circum- 
flex coronary artery at rest (left) 
and during peak exercise (right). 
The characteristic vasodilatory re- 
sponse of the normal artery can be 
appreciated. 
ening by ultrasound has been shown to represent intimal 
hypertrophy and hyperplasia by histopathologic analysis 
(18,25,26). Although a modest degree of intimal thickening is 
seen with normal aging (25), the marked intimal abnormalities 
seen in the study group are uncommon. Significant intimal 
thickening has been demonstrated occasionally in association 
with large atheromatous plaques (19,27), but in the absence of 
atherosclerosis such abnormalities have been seen only in 
cardiac transplant recipients with accelerated graft arteriopa- 
thy (28). This unexpected finding is intriguing and deserves 
further investigation. 
Vasomotor function. It has been demonstrated previously 
that normal coronary arteries dilate during exercise, whereas 
arteries with atherosclerotic disease constrict during exercise 
(29,30). The mechanism of exercise-induced narrowing of 
diseased arteries is believed to be due to endothelial damage/ 
dysfunction, with insutficient production of endothelium- 
derived relaxing factor (nitric oxide) (22,31-33). 
The vasomotor responses of the three syndrome X sub- 
groups identified by intravascular ultrasound are consistent 
with the previous principles. The group with normal coronary 
arteries displayed the expected vasodilatory response to exer- 
cise; this response probably represents an endothelium- 
mediated response to increasing blood flow (34). Conversely, 
the groups with disease by intravascular ultrasound, whether 
atheromatous disease or marked intimal proliferation, dis- 
played an abnormal vasoconstrictive r sponse to exercise 
consistent with dysfunctional endothelial response (30-34). 
The degree of vasodilation and vasoconstriction seen in this 
study is consistent with data from previous investigators 
(21,22,29-34). 
Propranolol loading produced a small but significant de- 
crease in baseline lumen area. It was demonstrated previously 
that propranolol reduces myocardial blood flow (35,36) and 
can reduce coronary lumen area at rest (35-38). Coronary 
blood flow after propranolol loading also has been shown to 
decrease during exercise (22,39) in patients free of coronary 
artery disease. Thus, the blunting of the vasodilatory response 
to exercise seen in the group with normal intravascular ultra- 
sound findings is not surprising and presumably reflects a 
decrease innitric oxide release because of relatively decreased 
coronary blood flow compared with that during exercise with- 
out beta-blockade. The effect of propranolol on coronary 
blood flow in patients with atherosclerosis is less well under- 
stood, but experimental work has suggested that it has a 
modest vasodilatory effect in diseased arteries during exercise 
(39). This may account for the attenuation f the vasoconstrie- 
tire response to exercise seen in the groups with abnormal 
ultrasound findings after propranolol loading. 
Because propranolol is a drug commonly used to treat 
angina, both in syndrome X and in classic coronary artery 
disease, the mixed vasomotor effects seen in this study are 
potentially of therapeutic import. 
Limitations of the study. The absence of an age-matched 
asymptomatic control group with normal coronary arteries by 
angiography is of concern. The spectrum of ultrasound findings 
Figure 3. Intravascular ultrasound 
image of an abnormal mid-left an- 
terior descending coronary artery 
at rest (left) and during peak exer- 
cise (right). There is marked thick- 
ening of the intimal layer (I). The 
typical vasoconstrictive response to
exercise seen in abnormal coronary 
arteries i displayed. 
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in a normal population has not been well defined because of 
the ethical difficulties in recruiting such subjects for an invasive 
study. Nevertheless, the available data from cardiac transplant 
recipients, from small studies of patients with normal coronary 
arteries referred for catheterization a d ultrasound for other 
indications and from necropsy series (17,19,20,24,25,40,41) 
suggest hat the extent of both atheromatous disease and 
intimal hypertrophy seen in the present study is significantly 
greater than the minor abnormalities that might be found in 
age-matched control subjects. 
The issue of possible nonequivalence of exercise before and 
after beta-blockade might cast doubt on the attenuation of
vasomotion observed after propranol administration i our 
study. The absence of a bicycle ergometer in our catheteriza- 
tion laboratory made it impossible to assess exercise work load 
quantitatively. However, our exercise protocol was rigorous 
and demanded an exercise duration and target heart rate 
considerably greater than those used in previous tudies (22), 
and we insisted on exact duplication of the intensity and 
duration of exercise after propranolol loading. In addition, our 
findings on the vasomotor effects of beta-blockade before and 
after exercise are consistent with the work of previous investi- 
gators (22,35,36-39). 
It should be noted that although all study patients with 
normal arteries by intravascular ultrasound had a normal 
vasomotor response to exercise, the absence of ultrasound 
abnormalities does not guarantee normal endothelial function. 
Reddy et al. (42) have shown an abnormal vasoconstrictive 
response to acetylcholine in some patients with normal coro- 
nary arteries by ultrasound who have a high number of risk 
factors for coronary artery disease. The modest risk factor 
score in our study may explain the preservation of normal 
vasomotor responses in our group of patients with normal 
intravascular ultrasound findings. 
Conclusions. Intravascular ultrasound emonstrates that 
most patients with syndrome X have abnormal epicardial 
coronary arteries. Intravascular ultrasound identifies three 
morphologic groups: true normal arteries, atherosclerotic dis- 
ease and marked intimal thickening without plaque. The 
vasomotor response to exercise is normal in patients with 
syndrome X who have normal coronary arteries by intravascu- 
lar ultrasound and is abnormal (vasoconstrictive) in patients 
with abnormal coronary arteries (atheroma or intimal thicken- 
ing). Abnormal stress imaging suggests abnormal coronary 
arteries by ultrasound; conventional stress testing correlates 
less well with ultrasound findings. Propranolol loading atten- 
uates both the normal vasodilatory and the abnormal vasocon- 
strictive response in patients with syndrome X and therefore 
might be of greater benefit in patients with abnormal coronary 
arteries by ultrasound. 
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